| pubmed-article:8627055 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8627055 | lifeskim:mentions | umls-concept:C0205725 | lld:lifeskim |
| pubmed-article:8627055 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:8627055 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:8627055 | lifeskim:mentions | umls-concept:C1446680 | lld:lifeskim |
| pubmed-article:8627055 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:8627055 | pubmed:dateCreated | 1996-6-21 | lld:pubmed |
| pubmed-article:8627055 | pubmed:abstractText | The mechanisms of inhibition of cytomegalovirus (CMV) infection by human CD13 (aminopeptidase N)-specific antibodies were studied. These antibodies protect CD13-negative and -positive cells from CMV infection only if incubated with the virus inoculum, suggesting they bind to CMV virions. The association of a CD13-like molecule with virions was further supported by the transfer of CD13 immunoreactivity to the surface of CD13-negative cells upon binding of CMV; the binding of CD13-specific antibodies directly to the surface of CMV virions; and the presence of anti-CD13 immunoreactive bands, including one with mobility similar to that of native cellular CD13 on immunoblots of proteins of purified CMV particles. Importantly, CD13-specific antibodies neutralize CMV in urine of neonates with congenital CMV, indicating that the CD13-like molecule is associated with natural CMV and not acquired in vitro. These studies demonstrate that a CD13-like molecule is associated with CMV particles and may be important in CMV pathogenesis. | lld:pubmed |
| pubmed-article:8627055 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8627055 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8627055 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8627055 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:8627055 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8627055 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8627055 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8627055 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8627055 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8627055 | pubmed:month | May | lld:pubmed |
| pubmed-article:8627055 | pubmed:issn | 0022-1899 | lld:pubmed |
| pubmed-article:8627055 | pubmed:author | pubmed-author:MöllerEE | lld:pubmed |
| pubmed-article:8627055 | pubmed:author | pubmed-author:ZaiaJ AJA | lld:pubmed |
| pubmed-article:8627055 | pubmed:author | pubmed-author:KIMS BSB | lld:pubmed |
| pubmed-article:8627055 | pubmed:author | pubmed-author:GiugniT DTD | lld:pubmed |
| pubmed-article:8627055 | pubmed:author | pubmed-author:SöderbergCC | lld:pubmed |
| pubmed-article:8627055 | pubmed:author | pubmed-author:HedlundK OKO | lld:pubmed |
| pubmed-article:8627055 | pubmed:author | pubmed-author:BautistaR MRM | lld:pubmed |
| pubmed-article:8627055 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8627055 | pubmed:volume | 173 | lld:pubmed |
| pubmed-article:8627055 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8627055 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8627055 | pubmed:pagination | 1062-71 | lld:pubmed |
| pubmed-article:8627055 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:meshHeading | pubmed-meshheading:8627055-... | lld:pubmed |
| pubmed-article:8627055 | pubmed:year | 1996 | lld:pubmed |
| pubmed-article:8627055 | pubmed:articleTitle | Neutralization of human cytomegalovirus by human CD13-specific antibodies. | lld:pubmed |
| pubmed-article:8627055 | pubmed:affiliation | Division of Pediatrics, City of Hope National Medical Center, Duarte, California 91010-0269, USA. | lld:pubmed |
| pubmed-article:8627055 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8627055 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:8627055 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8627055 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8627055 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8627055 | lld:pubmed |
